Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia

NCT05057221 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped No more eligible patients were available.

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Uproleselan

Sponsor

Lena Napolitano, MD

Collaborators

[object Object]